Exact Sciences Soars on $2.15 Billion Deal for Testing Firm

(Bloomberg) -- Exact Sciences Corp. said it will acquire Thrive Earlier Detection Corp. to gain technology for cancer screening in a deal worth as much as $2.15 billion.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.